Crystal structure of (2E)-2-[1-(4-bromophenyl)-3-(1H-imidazol-1-yl) propylidene]-N-(2,4-dichlorophenyl)hydrazinecarboxamide, C19H16BrCl2N5O

C19H16BrCl2N5O, triclinic, P1̅ (no. 2), a = 7.4661(3) Å, b = 10.9874(4) Å, c = 12.8619(5) Å, ɑ = 109.979(3)°, β = 92.053(3)°, γ = 95.677(3)°, V = 984.0 Å3, Z = 2, Rgt(F) = 0.0653, wRref(F2) = 0.1906, T = 296 K.

Bibliographic Details
Main Authors: Al-Wabli Reem I., Attia Mohamed I., Ghabbour Hazem A., El-Sayed Nahed N. E., Fun Hoong-Kun
Format: Article
Language:English
Published: De Gruyter 2015-09-01
Series:Zeitschrift für Kristallographie - New Crystal Structures
Online Access:https://doi.org/10.1515/ncrs-2014-9078
Description
Summary:C19H16BrCl2N5O, triclinic, P1̅ (no. 2), a = 7.4661(3) Å, b = 10.9874(4) Å, c = 12.8619(5) Å, ɑ = 109.979(3)°, β = 92.053(3)°, γ = 95.677(3)°, V = 984.0 Å3, Z = 2, Rgt(F) = 0.0653, wRref(F2) = 0.1906, T = 296 K.
ISSN:1433-7266
2197-4578